Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson’s Disease

QIIME allows analysis of high-throughput community sequencing data

Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · see citing works

Search and clustering orders of magnitude faster than BLAST

Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,617 · see citing works

Parkinson's disease

Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,412 · see citing works

The Microbiota-Gut-Brain Axis

Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286 · see citing works

Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease

Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622 · see citing works

Host microbiota constantly control maturation and function of microglia in the CNS

Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569 · see citing works

The gut microbiota influences blood-brain barrier permeability in mice

Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., Korecka, A., Bakocevic, N., Ng, L. G., Kundu, P., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009759 · Cited by 2,530 · see citing works

Non-motor features of Parkinson disease

Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.62 · Cited by 2,053 · see citing works

Gut microbiota are related to Parkinson's disease and clinical phenotype

Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · see citing works

Interactions between the microbiota, immune and nervous systems in health and disease

Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017) · Nature Neuroscience · doi:10.1038/nn.4476 · Cited by 1,900 · see citing works

Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology

Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354 · see citing works

Colonic bacterial composition in Parkinson's disease

Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281 · see citing works

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls

Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159 · see citing works

In-feed antibiotic effects on the swine intestinal microbiome

Looft, T., Johnson, T. A., Allen, H. K., Bayles, D. O., Alt, D. P., Stedtfeld, R. D., Sul, W. J., Stedtfeld, T. M., Chai, B., Cole, J. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120238109 · Cited by 1,072 · see citing works

Gastrointestinal Dysfunction in Parkinson’s Disease

Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00007-1 · Cited by 1,016 · see citing works

Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut

Barcenilla, A., Pryde, S. E., Martin, J. C., Duncan, S. H., Stewart, C. S., Henderson, C., & Flint, H. J. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.4.1654-1661.2000 · Cited by 996 · see citing works

Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota

Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901 · see citing works

Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome

Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874 · see citing works

Acetate Utilization and Butyryl Coenzyme A (CoA):Acetate-CoA Transferase in Butyrate-Producing Bacteria from the Human Large Intestine

Duncan, S. H., Barcenilla, A., Stewart, C. S., Pryde, S. E., & Flint, H. J. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.10.5186-5190.2002 · Cited by 743 · see citing works

Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4/TNF-α signaling pathway

Sun, M.-F., Zhu, Y.-L., Zhou, Z.-L., Jia, X.-B., Xu, Y.-D., Yang, Q., Cui, C., & Shen, Y.-Q. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.005 · Cited by 736 · see citing works

Understanding Dopaminergic Cell Death Pathways in Parkinson Disease

Michel, P. P., Hirsch, É. C., & Hunot, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.038 · Cited by 594 · see citing works

Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged Fischer 344 rats and Caenorhabditis elegans

Chen, S. G., Stribinskis, V., Rane, M. J., Demuth, D. R., Gozal, E., Roberts, A. M., Jagadapillai, R., Liu, R., Choe, K., Shivakumar, B., et al. (2016) · Scientific Reports · doi:10.1038/srep34477 · Cited by 463 · see citing works

A gut bacterial amyloid promotes α-synuclein aggregation and motor impairment in mice

Sampson, T. R., Challis, C., Jain, N., Moiseyenko, A., Ladinsky, M. S., Shastri, G. G., Thron, T., Needham, B. D., Horvath, I., Debelius, J. W., et al. (2020) · eLife · doi:10.7554/elife.53111 · Cited by 439 · see citing works

Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features

Li, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., & Qin, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9001-4 · Cited by 406 · see citing works

Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression

Aho, V. T. E., Pereira, P. A. B., Voutilainen, S., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.064 · Cited by 361 · see citing works

A simple quantitative bradykinesia test in MPTP-treated mice.

Ogawa, N., Hirose, Y., Ohara, S., Ono, T., & Watanabe, Y. (1985) · PubMed · Cited by 334 · see citing works

Gut microbiota in patients with Parkinson's disease in southern China

Lin, A., Zheng, W., He, Y., Tang, W., Wei, X., He, R., Huang, W., Su, Y., Huang, Y., Zhou, H., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.05.007 · Cited by 253 · see citing works

Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study

Wu, T., Zhang, Z., Liu, B., Hou, D., Liang, Y., Zhang, J., & Shi, P. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-669 · Cited by 234 · see citing works

Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity

Srivastav, S., Neupane, S., Bhurtel, S., Katila, N., Maharjan, S., Choi, H., Hong, J. T., & Choi, D.-Y. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.03.021 · Cited by 212 · see citing works

Oral and nasal microbiota in Parkinson's disease

Pereira, P. A. B., Aho, V. T. E., Paulin, L. G., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.02.026 · Cited by 207 · see citing works

Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management

Adhami, V. M., Syed, D. N., Khan, N., & Mukhtar, H. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.07.012 · Cited by 187 · see citing works

The Role of Functional Amyloids in Bacterial Virulence

Gerven, N. V., der Verren, S. E. V., Reiter, D. M., & Remaut, H. K. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.07.010 · Cited by 174 · see citing works

Lactobacillus Plantarum PS128 Alleviates Neurodegenerative Progression in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Mouse Models of Parkinson’s Disease

Liao, J.-F., Cheng, Y.-F., You, S.-T., Kuo, W.-C., Huang, C.-W., Chiou, J.-J., Hsu, C.-C., Hsieh-Li, H.-M., Wang, S., & Tsai, Y.-C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.07.036 · Cited by 159 · see citing works

Shifts in Lachnospira and Clostridium sp. in the 3-month stool microbiome are associated with preschool age asthma

Stiemsma, L. T., Arrieta, M., Dimitriu, P. A., Cheng, J., Thorson, L., Lefebvre, D. L., Azad, M. B., Subbarao, P., Mandhane, P. J., Becker, A. B., et al. (2016) · Clinical Science · doi:10.1042/cs20160349 · Cited by 133 · see citing works

Recurrence of ICA-PCoA aneurysms after neck clipping

Sakaki, T., TAKESHIMA, T., Tominaga, M., Hashimoto, H., & Kawaguchi, S. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.80.1.0058 · Cited by 102 · see citing works

Roles of Shiga Toxins in Immunopathology

Lee, M., & Tesh, V. L. (2019) · Toxins · doi:10.3390/toxins11040212 · Cited by 92 · see citing works

Antibiotic-Induced Microbiome Depletion Protects against MPTP-Induced Dopaminergic Neurotoxicity in the Brain

Pu, Y., Chang, L., Qu, Y., Wang, S., Zhang, K., & Hashimoto, K. (2019) · Aging · doi:10.18632/aging.102221 · Cited by 80 · see citing works

Dietary flavonoid fisetin binds to β-tubulin and disrupts microtubule dynamics in prostate cancer cells

Mukhtar, E., Adhami, V. M., Sechi, M., & Mukhtar, H. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.030 · Cited by 77 · see citing works

Human behavioral assessments in current research of Parkinson’s disease

Asakawa, T., Fang, H., Sugiyama, K., Nozaki, T., Kobayashi, S. S., Hong, Z., Suzuki, K., Mori, N., Yang, Y., Hua, F., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.036 · Cited by 75 · see citing works

Protective effects of fisetin and other berry flavonoids in Parkinson's disease

Maher, P. A. (2017) · Food & Function · doi:10.1039/c7fo00809k · Cited by 75 · see citing works

Animal behavioral assessments in current research of Parkinson’s disease

Asakawa, T., Fang, H., Sugiyama, K., Nozaki, T., Hong, Z., Yang, Y., Hua, F., Ding, G., Chao, D., Fenoy, A. J., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.016 · Cited by 68 · see citing works

Fisetin decreases TET 1 activity and CCNY / CDK 16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cell

Si, Y., Liu, J., Shen, H., Zhang, C., Wu, Y., Huang, Y., Gong, Z., Xue, J., & Liu, T. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14010 · Cited by 61 · see citing works

Noninvasive in vivo assessment of muscle impairment in the mdx mouse model – A comparison of two common wire hanging methods with two different results

Klein, S., Vykoukal, J. V., Lechler, P., Zeitler, K., Gehmert, S., Schreml, S., Alt, E., Bogdahn, U., & Prantl, L. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.10.001 · Cited by 61 · see citing works

Fisetin Improved Rotenone-Induced Behavioral Deficits, Oxidative Changes, and Mitochondrial Dysfunctions in Rat Model of Parkinson’s Disease

Alikatte, K., Palle, S., Jadi, R. K., & Pathakala, N. (2020) · Journal of Dietary Supplements · doi:10.1080/19390211.2019.1710646 · Cited by 57 · see citing works

The Gut and Nonmotor Symptoms in Parkinson's Disease

Klingelhoefer, L., & Reichmann, H. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.027 · Cited by 53 · see citing works

New insight into the molecular control of bacterial functional amyloids

Taylor, J. D., & Matthews, S. (2015) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2015.00033 · Cited by 51 · see citing works

The Neuroprotective Effect of Fisetin in the MPTP Model of Parkinson's Disease

Patel, M. Y., Panchal, H., Ghribi, O., & Benzeroual, K. E. (2012) · Journal of Parkinson s Disease · doi:10.3233/jpd-012110 · Cited by 51 · see citing works

α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology

Christiansen, J. R., Olesen, M. N., Otzen, D. E., Romero‐Ramos, M., & Sánchez-Guajardo, V. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0532-8 · Cited by 37 · see citing works

Genistein Inhibits Aβ25–35-Induced Neuronal Death with Changes in the Electrophysiological Properties of Voltage-Gated Sodium and Potassium Channels

Wang, Y., Xia, Z., Jiang, X., Li, L., An, D., Wang, H., Heng, B., & Liu, Y. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00680-w · Cited by 13 · see citing works

The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress

Hassan, S. S. U., Samanta, S., Dash, R., Karpiński, T. M. M., Habibi, E., Sadiq, A., Ahmadi, A., & BUNGAU, S. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1015835 · Cited by 139 · see citing works

Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson’s disease

Cui, C., Han, Y., Li, H., Yu, H., Zhang, B., & Li, G. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.887407 · Cited by 110 · see citing works

Fisetin, potential flavonoid with multifarious targets for treating neurological disorders: An updated review

Ravula, A. R., Teegala, S. B., Shanker, K., Pasangulapati, J. P., Perumal, V., & Boyina, H. K. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174492 · Cited by 96 · see citing works

Anti-Oxidative, Anti-Inflammatory and Anti-Apoptotic Effects of Flavonols: Targeting Nrf2, NF-κB and p53 Pathways in Neurodegeneration

Jembrek, M. J., Oršolić, N., Mandić, L., Sadžak, A., & Šegota, S. (2021) · Antioxidants · doi:10.3390/antiox10101628 · Cited by 99 · see citing works

The Interaction of Polyphenols and the Gut Microbiota in Neurodegenerative Diseases

Zhang, Y., Yu, W., Zhang, L., Wang, M., & Chang, W. (2022) · Nutrients · doi:10.3390/nu14245373 · Cited by 95 · see citing works

Emerging Interrelationship Between the Gut Microbiome and Cellular Senescence in the Context of Aging and Disease: Perspectives and Therapeutic Opportunities

Sharma, R. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09903-3 · Cited by 80 · see citing works

Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease

Li, T., Chu, C., Yu, L., Zhai, Q., Wang, S., Zhao, J., Zhang, H., Chen, W., & Tian, F. (2022) · Nutrients · doi:10.3390/nu14214678 · Cited by 76 · see citing works

Fisetin Improves Hyperuricemia-Induced Chronic Kidney Disease via Regulating Gut Microbiota-Mediated Tryptophan Metabolism and Aryl Hydrocarbon Receptor Activation

Ren, Q., Cheng, L., Guo, F., Tao, S., Zhang, C., Ma, L., & Fu, P. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c03449 · Cited by 71 · see citing works

Human Umbilical Cord Mesenchymal Stem Cells Improve Locomotor Function in Parkinson’s Disease Mouse Model Through Regulating Intestinal Microorganisms

Sun, Z., Gu, P., Xu, H., Zhao, W., Zhou, Y., Zhou, L., Zhang, Z., Wang, W., Han, R., Chai, X.-Q., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.808905 · Cited by 55 · see citing works

Integrating Ethnobotany, Phytochemistry, and Pharmacology of Cotinus coggygria and Toxicodendron vernicifluum: What Predictions can be Made for the European Smoketree?

Antal, D., Ardelean, F., Jîjie, A.-R., Pînzaru, I., Şoica, C., & Dehelean, C. A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.662852 · Cited by 44 · see citing works

Modulatory Effects of Phytochemicals on Gut–Brain Axis: Therapeutic Implication

Jaberi, K. R., Alamdari-Palangi, V., Savardashtaki, A., Vatankhah, P., Jamialahmadi, T., Tajbakhsh, A., & Sahebkar, A. (2024) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2024.103785 · Cited by 44 · see citing works

Effects of Fisetin, a Plant-Derived Flavonoid, on Response to Oxidative Stress, Aging, and Age-Related Diseases in Caenorhabditis elegans

Park, S.-H., Kim, B.-K., & Park, S.-K. (2022) · Pharmaceuticals · doi:10.3390/ph15121528 · Cited by 42 · see citing works

Harnessing the therapeutic potential of fisetin and its nanoparticles: Journey so far and road ahead

Vishwas, S., Singh, S. K., Gulati, M., Awasthi, A., Khursheed, R., Corrie, L., Kumar, R., Collet, T., Löebenberg, R., Porwal, O., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109869 · Cited by 39 · see citing works

Fisetin Promotes Functional Recovery after Spinal Cord Injury by Inhibiting Microglia/Macrophage M1 Polarization and JAK2/STAT3 Signaling Pathway

Ji, R., Hao, Z., Wang, H., Su, Y., Yang, W., Li, X., Duan, L., Guan, F., & Ma, S. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c02985 · Cited by 36 · see citing works

Dietary (Poly)phenols and the Gut–Brain Axis in Ageing

Láng, L., McArthur, S., Lázár, A. S., Pourtau, L., Gaudout, D., Pontifex, M. G., Müller, M. M., & Vauzour, D. (2024) · Nutrients · doi:10.3390/nu16101500 · Cited by 31 · see citing works

Crosstalk between gut–brain axis: unveiling the mysteries of gut ROS in progression of Parkinson’s disease

Soni, D., Upadhayay, S., Dhureja, M., Arthur, R., & Kumar, P. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01510-2 · Cited by 31 · see citing works

Therapeutic Potential and Molecular Mechanisms of the Multitargeted Flavonoid Fisetin

Rauf, A., Abu‐Izneid, T., Imran, M., Hemeg, H. A., Bashir, K., Aljohani, A. S. M., Aljohani, M. S. M., Alhumaydhi, F. A., Khan, I. N., Emran, T. B., et al. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230710162217 · Cited by 29 · see citing works

Neuronutrition and Nrf2 Brain Resilience Signaling: Epigenomics and Metabolomics for Personalized Medicine in Nervous System Disorders from Bench to Clinic

Scuto, M. C., Anfuso, C. D., Lombardo, C., Fatta, E. D., Ferri, R., Musso, N., Zerbo, G., Terrana, M., Majzúnová, M., Lupo, G., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199391 · Cited by 28 · see citing works

The Neuroprotective Role of Fisetin in Different Neurological Diseases: a Systematic Review

Jiang, Y., Tang, X., Deng, P., Jiang, C. Q., He, Y., Hao, D., & Yang, H. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03469-7 · Cited by 27 · see citing works

Small Molecule Fisetin Modulates Alpha–Synuclein Aggregation

Rosado-Ramos, R., Godinho-Pereira, J., Marques, D., Figueira, I., Outeiro, T. F., Menezes, R., & dos Santos, C. N. (2021) · Molecules · doi:10.3390/molecules26113353 · Cited by 22 · see citing works

Antiparkinsonian effects of polyphenols: A narrative review with a focus on the modulation of the gut-brain axis

Zhang, W., Dong, X., & Huang, R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106787 · Cited by 21 · see citing works

Supplement and nutraceutical therapy in traumatic brain injury

Lucke-Wold, B., Zasler, N., Ruchika, F., Weisman, S., Le, D., Brunicardi, J., Kong, I., Ghumman, H., Persad, S., Mahan, D. S., et al. (2024) · Nutritional neuroscience · doi:10.1080/1028415x.2024.2404782 · Cited by 14 · see citing works

FIsetin Preserves Interfibrillar Mitochondria to Protect Against Myocardial Ischemia-Reperfusion Injury

Shanmugam, K., Prem, P. N., Boovarahan, S. R., Sivakumar, B., & Kurian, G. A. (2021) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-021-01026-4 · Cited by 19 · see citing works

Advances in Neuropathic Pain Research: Selected Intracellular Factors as Potential Targets for Multidirectional Analgesics

Ciapała, K., & Mika, J. (2023) · Pharmaceuticals · doi:10.3390/ph16111624 · Cited by 19 · see citing works

Fisetin-loaded chitosan nanoparticles ameliorate pilocarpine-induced temporal lobe epilepsy and associated neurobehavioral alterations in mice: Role of ROS/TNF-α-NLRP3 inflammasomes pathway

Mahawar, S., Rakshit, D., Patel, I., Gore, S. K., Sen, S., Ranjan, O. P., & Mishra, A. (2024) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2024.102752 · Cited by 19 · see citing works

Nurturing longevity through natural compounds: Where do we stand, and where do we go?

Todorova, M. N., Savova, M. S., Mihaylova, L. V., & Georgiev, M. I. (2024) · Food Frontiers · doi:10.1002/fft2.350 · Cited by 17 · see citing works

Convergence of Neuroinflammation, Microbiota, and Parkinson’s Disease: Therapeutic Insights and Prospects

Rojo, N. D., Blanco-Benítez, M., Cava, R., Fuentes, J. M., Canales-Cortés, S., & González‐Polo, R. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111629 · Cited by 17 · see citing works

Nanoformulated fisetin ameliorates Alzheimer's disease via reducing proinflammatory cytokines and activating the NRF2/HO-1 pathway

Rakshit, D., Goyal, R., Yadav, V. K., Gore, S. K., Sen, S., Ranjan, O. P., & Mishra, A. (2024) · Nanomedicine · doi:10.1080/17435889.2024.2419814 · Cited by 16 · see citing works

Sika Deer Velvet Antler Peptide Exerts Neuroprotective Effect in a Parkinson’s Disease Model via Regulating Oxidative Damage and Gut Microbiota

Liu, Y., Li, H., Yang, M., Guo, J., Sun, Z., Wang, S., Li, R., Pang, X., Kim, Y., Wang, X., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17070972 · Cited by 16 · see citing works

Impact of gut microbiota in chronic kidney disease: natural polyphenols as beneficial regulators

Cheng, L., Chen, X., Zha, W., Fang, S., Shen, J., Li, L., Jiang, H., & Tian, P. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2506810 · Cited by 17 · see citing works

The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson’s Disease

Yao, L., Yang, Y., Yang, X., & Rezaei, M. J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04151-2 · Cited by 13 · see citing works

The effects of polyphenols on gut microbial metabolites and composition in neurodegenerative diseases: a systematic review

Zafari, R., Goudarzi, N., Kamroo, A., Tafti, M. F., Ghorbani, A., Talebian, N., Najafi, S., Shahbazian, S., Rahmanian, M., Parvardeh, S., et al. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-01022-y · Cited by 12 · see citing works

Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research

Khan, M. A., Haider, N., Singh, T., Bandopadhyay, R., Ghoneim, M. M., Alshehri, S., Taha, M., Ahmad, J., & Mishra, A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01180-z · Cited by 12 · see citing works

Orally Administered Fisetin Reduces the Symptoms of Acute Allergic Asthma in a Preclinical Mouse Model

Mitra, S., Ghosh, N., Paul, P., & Banerjee, E. R. (2022) · Biomedical Research and Therapy · doi:10.15419/bmrat.v9i3.731 · Cited by 11 · see citing works

Fisetin as a multifunctional bioactive flavonoid: A comprehensive review of its pharmacology, mechanism of action, safety profile, clinical trials, and future directions in therapeutics

Khan, S., Khan, M. M., Badruddeen, B., Ahmad, U., & Khan, S. A. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107620 · Cited by 10 · see citing works

From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes

Widjaja, F., & Rietjens, I. M. C. M. (2023) · Biomedicines · doi:10.3390/biomedicines11102658 · Cited by 10 · see citing works

An insight into fisetin, the miraculous multifaceted flavonol: Paving the road for enhanced delivery through promising pharmaceutical nano-formulations

Elwan, A. H., El-Masry, S. M., Habib, D. A., & Zewail, M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106292 · Cited by 9 · see citing works

Effect of Flavonoids against Parkinson’s Disease

Varshney, H., & Siddique, Y. H. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249264078231214074107 · Cited by 7 · see citing works

Evaluation of fisetin as a potential inducer of mitochondrial biogenesis in SH-SY5Y neuronal cells.

Ay, M. (2023) · PubMed Central · doi:10.22038/ijbms.2023.72272.15714 · Cited by 7 · see citing works

Role of Cellular Senescence in Parkinson’s Disease: Potential for Disease-Modification Through Senotherapy

Rademacher, D. J., Exline, J. E., & Foecking, E. M. (2025) · Biomedicines · doi:10.3390/biomedicines13061400 · Cited by 7 · see citing works

Fisetin: a multitarget flavonol bridging oxidative stress, inflammation, aging, and cancer

Chahal, S. K., Kabra, A., Saeedan, A. S., & Ansari, M. N. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04912-3 · Cited by 5 · see citing works

The Possible Ameliorating Role of Fisetin on Hepatic Changes Induced by Fluoxetine in Adult Male Albino Rats: Histological, Immunohistochemical, and Biochemical Study

Shaer, D. F. E., & Halim, H. I. A. E. (2023) · Journal of Microscopy and Ultrastructure · doi:10.4103/jmau.jmau_84_22 · Cited by 5 · see citing works

The Role of Polyphenols on Cognitive Function and Dementia Through Gut–Microbiota–Brain Axis Modulation: A Narrative Review

Sbai, O., Chaure, A., Perrone, L., & Poucheret, P. (2026) · Nutrients · doi:10.3390/nu18111697 · Cited by 4 · see citing works

MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modeling of Parkinson’s Disease

Ferrucci, M., & Fornai, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_239-1 · Cited by 4 · see citing works

Novel insights into ORFV B2L DNA vaccine-mediated gut microbiota modulation and immune augmentation in rats

Farooq, U., Liu, G., Ahmed, S., Yang, H., Ahmed, M., & Jiang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1598969 · Cited by 3 · see citing works

Mechanistic and hormetic insights into the interaction between dietary bioactive compounds and gut microbiota in modulating human health

Elumalai, A., & Natarajan, V. (2025) · Food Chemistry Advances · doi:10.1016/j.focha.2025.101190 · Cited by 3 · see citing works

A neuroprotective effect of newly isolated probiotic bacterium Lactobacillus acidophilus SLAM_LAA02 in a rotenone-induced mouse model of Parkinson’s disease

Kim, Y., Seo, E., Kang, A., Kang, M.-G., Jang, K. B., Oh, S., & Kim, Y. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118896 · Cited by 3 · see citing works

Neuroprotection via gut microbiota: Role of curcumin and resveratrol: An updated systematic review

Pauline, R., Murugesan, K., Radhakrishnan, A., Kandaswamy, D., Growther, L., Ganapathy, P., & Subbaraj, G. K. (2025) · Food and Humanity · doi:10.1016/j.foohum.2025.100824 · Cited by 3 · see citing works

Research progress on natural products in regulating the gut microbiota in Parkinson’s disease

Jia, Y., Zhang, Y., Tai, X., Zhao, T., Zhang, H., & Zhou, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1667694 · Cited by 4 · see citing works

Microbiome-Based Therapies in Parkinson’s Disease: Can Tuning the Microbiota Become a Viable Therapeutic Strategy?

Onaolapo, A. Y., Ojo, F. O., Olofinnade, A. T., Falade, J., Lawal, I. A., & Onaolapo, O. J. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220903114559 · Cited by 3 · see citing works

Effect of Adding Alkaline Metal Ions Complexes Rumen Microbiota and Metabolome of Hu Lambs

Li, M., Ma, C., Li, Y., An, Z., Yang, Y., Gao, F., Li, C., & Liu, Y. (2025) · Animals · doi:10.3390/ani15121816 · Cited by 2 · see citing works

Gut bacteria composition in animal models of Parkinson’s disease: a systematic review and meta-analysis

Elford, J. D., Heesbeen, E. J., van der Plaats, N. A., Garssen, J., Kraneveld, A. D., Groenink, L., & Perez‐Pardo, P. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-025-01236-0 · Cited by 2 · see citing works

Mulberry, Gut Microbiota and Gut Functionality: Effects Shaped by Raw Material and Processing Methods

Miszczak, M. M., Kłosowska-Buryło, K., Pieczyńska, J. M., Bielecka, M., & Prescha, A. (2026) · Biomolecules · doi:10.3390/biom16070965 · Cited by 2 · see citing works

MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modeling of Parkinson’s Disease

Ferrucci, M., & Fornai, F. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_239 · Cited by 1 · see citing works

Impacts of Senolytic Phytochemicals on Gut Microbiota: A Comprehensive Review

Kim, H. S., & Jung, C. H. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2408.08032 · Cited by 1 · see citing works

Effect and mechanism of fisetin against the development of metabolic dysfunction-associated fatty liver disease

Peng, X., Wei, Z., Liu, S., Liu, L., Jiang, H., Yu, L., Xu, X., & Gu, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-96848-0 · Cited by 1 · see citing works

Polyphenol-Loaded Plant Extracellular Vesicles: A New Approach to Combat AGEs-Induced Neurotoxicity via the Microbiota-Gut-Brain Axis

Cao, Y., Wang, R., Ni, Z., Luo, T., & Zhang, X. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c08992 · Cited by 1 · see citing works

Pharmacological mechanisms of fisetin in neurodegenerative disorders: regulation of neuroinflammatory, oxidative, and autophagic pathways

Singh, A., Singh, L., & Dalal, D. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05656-4 · Cited by 1 · see citing works

Senolytika und Senomorphika im Kampf gegen neurodegenerative Erkrankungen

Gröber, U., & Friedrichsen, H.-P. (2024) · Zeitschrift für Komplementärmedizin · doi:10.1055/a-2360-5309 · Cited by 1 · see citing works

Neuropharmacology of Fisetin as a Senotherapeutic Agent: Investigating Its Role in Neurodegeneration and Brain Aging

Javaid, S., Memon, A., Anwar, B., Bader, Z., Aftab, A., Perveen, F., & Haq, E. U. (2024) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v5i11.2399 · Cited by 1 · see citing works

Fisetin: Advances on Resources, Biosynthesis Pathway, Bioavailability, Bioactivity, and Pharmacology

Luca, S. V., & Trifan, A. (2023) · Springer eBooks · doi:10.1007/978-3-030-94753-8_23-1

Senolytika und Senomorphika im Kampf gegen neurodegenerative Erkrankungen

Gröber, U., & Friedrichsen, H.-P. (2024) · Zeitschrift für Orthomolekulare Medizin · doi:10.1055/a-2268-0285

Neurodegenerative Natural Foes

Malik, I., Afzal, S., & Attiq, A. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-4139-2.ch014

Unravelling the multi-target mechanism of methoxylated flavonoids in Parkinson's disease: Insights from network pharmacology and molecular dynamics

Ashok, C., Jeyabalan, S., Pavadai, P., Vignesh, M., Devaraja Dravida Pandiyan, S., Mohan, D., Sugumar, R., Sugumar, R., Sugin Lal Jabaris, S., Subramaniyan, V., et al. (2026) · Toxicology Reports · doi:10.1016/j.toxrep.2026.102248

Non-pharmacological interventions modulating immune response in Parkinson's disease: where do we stand for future preventive approaches

Pirovano, E., Silva, I. P., Camacho, M., Canak, A., Aktaş, B., Crompton, D., Gökçe, E., Tan, F.-M., Marino, F., Domingos, J., et al. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106211

Flavonoids and neurodegeneration: Structure-activity relationship and therapeutic insights

Paragas, D. S., Ortinero, C., Feliciano, M. A. M., Lazaro, S. E., Quitos, L. S., Gonzales, R. L., Hsieh, C.-Y., Chen, B.-Y., Hsueh, C., & Tsai, P. (2026) · Studies in natural products chemistry · doi:10.1016/b978-0-443-49142-9.00010-x

Microbiome‐Phytochemical Crosstalk Along the Gut‐Brain Axis in Alzheimer and Parkinson's Disease

Emon, M., Rahaman, M. M., Sarder, D., Shadin, M., Neela, S. A., Wangchuk, P., & Sarker, S. (2026) · MicrobiologyOpen · doi:10.1002/mbo3.70374

Clinical Translation of Fisetin for Age-Related Diseases: Current Evidence and Future Opportunities

Sandoval-Caballero, C., Roemer, Z., Kotz, C. M., Puskarich, M. A., Mavanji, V., Schmidt, E. L., & Sibley, S. D. (2026) · Nutrients · doi:10.3390/nu18182999

Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson's disease mice via gut microbiota and metabolites

Zhou, Z.-L., Jia, X.-B., Sun, M.-F., Zhu, Y.-L., Qiao, C.-M., Zhang, B.-P., Zhao, L.-P., Yang, Q., Cui, C., Chen, X., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00719-2 · Cited by 195 · see citing works

Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4/TNF-α signaling pathway

Sun, M.-F., Zhu, Y.-L., Zhou, Z.-L., Jia, X.-B., Xu, Y.-D., Yang, Q., Cui, C., & Shen, Y.-Q. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.005 · Cited by 736 · see citing works

Announcement

(1995) · Experimental Neurology · doi:10.1006/exnr.1995.1076

Healthy Human Fecal Microbiota Transplantation into Mice Attenuates MPTP-Induced Neurotoxicity via AMPK/SOD2 Pathway

Xie, Z., Zhang, M., (512363), Y. L., Jin, D., Guo, X., (406666), W. Y., Zheng, J., Zhang, H., Zhang, L., (329151), C. D., et al. (2024) · Figshare

Intermittent fasting protects MPTP-induced Parkinson's disease mouse model through regulating gut microbiota dysbiosis

Qu, Y., Wang, P., Wang, D., Li, B., & Yang, F. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116447 · Cited by 4 · see citing works